Clinical trial
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in…
NCT00498953 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00498953 |
|---|---|
| Title | Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx |
| Official title | Phase I/II Study on Induction Chemotherapy Followed by Chemoradiation With or Without Lapatinib, a Dual EGFR/ErbB2 Kinase Inhibitor, in Patients With Locally Advanced Larynx and Hypopharynx Squamous Cell Carcinoma |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Genetic, Other, Procedure, Radiation |
| Interventions | carboplatin, cisplatin, docetaxel, fluorouracil, lapatinib ditosylate, cytogenetic analysis, fluorescence in situ hybridization, in situ hybridization, polymerase chain reaction, reverse transcriptase-polymerase chain reaction and 6 more |
| Enrollment | 7 |
| Start date | May 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Jul 11, 2007 |
| Last update posted | Jul 9, 2018 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: